A Very Meh-Ry Biotech Year and What’s Ahead in 2025

from The Bio Report · host Levine Media Group

We continue our holiday tradition by welcoming STAT News Senior Biotech Writer Adam Feuerstein for our annual look back at the year that was in biotech and what’s ahead for the industry with the JPMorgan Healthcare conference and beyond in 2025. Feuerstein offers his view on finance and dealmaking in 2024, new drug approvals, and his annual take on the best and worst CEOs of the year. We also discuss what Trump 2.0 may look like for the industry, changes coming to the FDA and other agencies, and what hot technologies to watch in the year ahead.

Episode metadata supplied by the publisher feed · Published Dec 25, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

A Very Meh-Ry Biotech Year and What’s Ahead in 2025

0:00 40:28

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Bio Report?

This episode is 40 minutes long.

When was this The Bio Report episode published?

This episode was published on December 25, 2024.

Can I download this The Bio Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!